|
|
||||||||
RESEARCH REPORT |
2 Integrin +807 Polymorphism in Drug-induced Gingival Overgrowth
1 Divison of Gene Expression, Institute for Genome Research, The University of Tokushima, Kuramoto 3-18-15, Tokushima 770-8503, Japan;
2 Department of Periodontology and Endodontology, Institute of Health Bioscience, Graduate School, The University of Tokushima;
3 Department of Pathophysiology/Periodontal Science, Okayama University Graduate School of Medical and Dentistry;
4 Divison of Periodontology, Department of Oral Biological Science, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan; and
5 Faculty of Pharmaceutical Science, University of Tokushima, Japan;
* corresponding author, kataoka{at}genome.tokushima-u.ac.jp
2 integrin on fibroblasts is reported to play an important role in the induction of drug-induced gingival overgrowth, which is characterized by excessive accumulation of type I collagen in gingival connective tissue. Silent polymorphism 807 T/C within the
2 integrin gene is associated with high/low
2 integrin expression. The aim of this study was to test the hypothesis that expression of
2 integrin 807 T/C polymorphism correlates with drug-induced gingival overgrowth. A case-control study comparing 136 subjects taking calcium channel blockers (72 with vs. 64 without drug-induced gingival overgrowth) demonstrated that the frequency of the +807 C allele was significantly higher in the case group than in the controls (odds ratio, 3.61; 95% confidence interval, 2.14 6.10; P < 0.05). The present findings suggest that the
2 +807 C allele is one of the genetic risk factors for drug-induced gingival overgrowth.
KEY WORDS: drug-induced gingival overgrowth
2 integrin SNP collagen phagocytosis
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| IADR Journals | Advances in Dental Research ® |
| Journal of Dental Research ® | Critical Reviews (1990-2004) |